Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

Mise à jour : Il y a 4 ans
Référence : NCT01923545

Femme et Homme

Extrait

This study is to examine which dose of DA-3031(PEG-G-CSF) has similar efficacy and safety compared to daily G-CSF in chemotherapy-induced neutropenia.


Critère d'inclusion

  • Chemotherapy induced Neutropenia

Liens